Atlas Trials

Study of Azacitidine,Venetoclax,and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP Patients

Clinical trial NCT05433532 · COMPLETED

Trial details

NCT number
NCT05433532
Sponsor
The First Affiliated Hospital of Soochow University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Philadelphia ChromosomeAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid LeukemiaMixed Phenotype Acute Leukemia
Start date
2022-05-01
Primary completion
2024-04-13
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.